Søgning på udtrykket 'covid' giver 80 resultater


Dokumenter [8] Sider [2] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [8]

Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: 1. Et af Paxlovid kriterierne ændret (fra ”Betydelige symptomer på COVID-19” til ”Mild eller moderat COVID-19”). 2. Døde links til infektionshygiejniske retningslinjer er fjernet, og nyt er indsat. 3. Tekst om afisolation.

Invitation til møde den 20. maj 2022

COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed

Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Der er ikke foretaget en gradering af evidensniveau. Ændringer i denne udgave: Remdesivir står ikke længere som relativt kontraindiceret ved påvirket nyrefunktion.

DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.

Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale

Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

Sider [2]

… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2023v26), Cystisk fibrose (SST's arbejdsgruppe til eftersyn af området vedrørende cyst…

Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…


Kalender [29]

16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Infection
26.02.2024
. Abstract. . Purpose. This aimed to identify the factors associated with severe/critical coronavirus disease 2019 (COVID-19) infection in rheumatoid arthritis (RA) patients. . . . Methods. Two-hundred RA patients diagnosed according to the American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR) classification criteria with proven C…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. Healthcare workers (HCWs) have a higher risk of contracting coronavirus disease 2019 (COVID-19) compared to the general population due to their frontline role and direct contact with the infected patients. Accordingly, they were among the first groups to receive vaccination against COVID-19. A higher risk of COVID-19 infection may also exist among hospital staff members other than HCWs. In this stud…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. Healthcare workers (HCWs) have a higher risk of contracting coronavirus disease 2019 (COVID-19) compared to the general population due to their frontline role and direct contact with the infected patients. Accordingly, they were among the first groups to receive vaccination against COVID-19. A higher risk of COVID-19 infection may also exist among hospital staff members other than HCWs. In this stud…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. Healthcare workers (HCWs) have a higher risk of contracting coronavirus disease 2019 (COVID-19) compared to the general population due to their frontline role and direct contact with the infected patients. Accordingly, they were among the first groups to receive vaccination against COVID-19. A higher risk of COVID-19 infection may also exist among hospital staff members other than HCWs. In this stud…
BMC Infectious Diseases
24.02.2024
… Abstract. . Purpose. To identify the key infection processes and risk factors in Computed Tomography (CT) examination process within the standard prevention and control measures for the COVID-19 epidemic, aiming to mitigate cross-infection occurrences in the hospital. . . . Method. The case hospital has assembled a team of 30 experts specialized in CT exa…
BMC Infectious Diseases
24.02.2024
. Abstract. . Introduction. It is important to identify the relationship between the COVID-19 vaccination status and the prognosis of this disease in hospitalized patients to gain a more accurate picture of their status and the effect of vaccination, as well as take necessary measures to improve their medical care. Thus, the present study was conducted to investigate the relationship between the vaccination status of hospita…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. People who have coronary artery disease are more likely to develop signs and symptoms of COVID-19 due to their special circumstances. Coronary artery bypass grafting surgery (CABG)does not cure the disease but reduces the signs and symptoms, therefore, there is a possibility of severe complications of Covid-19 after it. . . . Materials a…
BMC Infectious Diseases
24.02.2024
. Abstract. . Background. People who have coronary artery disease are more likely to develop signs and symptoms of COVID-19 due to their special circumstances. Coronary artery bypass grafting surgery (CABG)does not cure the disease but reduces the signs and symptoms, therefore, there is a possibility of severe complications of Covid-19 after it. . . . Materials a…
PLoS One Infectious Diseases
24.02.2024
…dence on protection of different patterns of infection- and vaccine-acquired immunity against Omicron-associated severe illness is useful in planning booster vaccination strategies. We examined protection of prior SARS-CoV-2 infection, a third or a fourth COVID-19 vaccine dose, and hybrid immunity against Omicron-associated severe illness. Methods and findings This population-based cohort study followed five million individuals with at least one SARS-CoV-2 RT-PCR test before November 21, 2021 until an Omic…
PLoS One Infectious Diseases
24.02.2024
…o Stephan Marie Gordts, Sotirios Tsimikas, Alexandre Biasi Cavalcanti . Background Halofuginone (PJS-539) is an oral prolyl-tRNA synthetase inhibitor that has a potent in vitro activity against SARS-CoV-2 virus. The safety and efficacy of halofuginone in Covid-19 patients has not been studied. Methods We conducted a phase II, randomized, double-blind, placebo-controlled, dose ranging, safety and tolerability trial of halofuginone in symptomatic (≤ 7 days), mostly vaccinated, non-hospitalized adults with…
Journal of Infectious Diseases
23.02.2024
Abstract . Background . We assessed associations between binding antibody (bAb) concentration
Science
23.02.2024
Science, Volume 383, Issue 6685, Page 830-832, February 2024.
Lancet
23.02.2024
In 2021, Breathtaking, palliative care consultant Rachel Clarke's memoir about the start of the COVID-19 pandemic, movingly captured the lived experiences of health-care workers in the UK's National Health Service (NHS). With co-writers Jed Mercurio and Prasanna Puwanarajah, who are both former physicians, Clarke has now adapted her book for television. This visual medium gives the narrative a power to reach further than the book to validate not only the experiences of staff, but also service users, and to …
PLoS One Infectious Diseases
23.02.2024
by Sanne Kaelen, Wilma van den Boogaard, Umberto Pellecchia, Sofie Spiers, Caroline De Cramer, Gwennin Demaegd, Edouard Fouqueray, Rafael Van den Bergh, Stephanie Goublomme, Tom Decroo, Muriel Quinet, Elke Van Hoof, Bertrand Draguez .
PLoS One Infectious Diseases
23.02.2024
by Augustine Ngmenemandel Balegha, Suburu Abdul-Aziz, Louis Mornah . Introduction The novel coronavirus SARS-CoV-2 causes Coronavirus Disease 2019 (COVID-19). Vaccination has been identified as one of the most effective strategies for combating COVID-19. Positive perceptions and attitudes of HCPs towards the COVID-19 vaccination are essential to vaccine uptake and adherence. However, the perceptions and attitudes of HCPs towards the COVID-19 vaccination remain largely unexplored. We therefore assessed heal…
PLoS One Infectious Diseases
23.02.2024
by Arrani Senthinathan, Stephanie Cimino, Susan B. Jaglal, B. Catharine Craven, Karen Tu, Sara Guilcher . Background Individuals with spinal cord injuries or disease (SCI/D) require frequent healthcare services. The COVID-19 pandemic may have impacted healthcare. Furthermore, due to secondary health conditions and comorbidities persons with SCI/D are at increased risk of experiencing severe symptoms or outcomes if infected with the COVID-19 virus. It is unclear to what extent research has investigated the …
International Journal of Infectious Diseases
23.02.2024
Vaccination against COVID-19 was the key measure in battling the pandemic and its effectiveness against death and severe course has been demonstrated in a multitude of studies. However, a vast majority of these studies (apart from registration studies) were observational. It has been proposed that observational studies are subject to inherent biases, including differences in testing strategies between vaccinated and unvaccinated groups or in determining the cause of death (with COVID vs due to COVID)[1,2].
BMC Infectious Diseases
22.02.2024
. Abstract. . Background. People who have coronary artery disease are more likely to develop signs and symptoms of COVID-19 due to their special circumstances. Coronary artery bypass grafting surgery (CABG)does not cure the disease but reduces the signs and symptoms, therefore, there is a possibility of severe complications of Covid-19 after it. . . . Materials a…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
23.02.2024
In recent days, there were several important new reports that help explain the pathophysiology of long COVID. The new findings are summarized here. . Medscape Medical News
Statens Serum Institut
23.02.2024
Verdens største studie af covid-19 vaccinernes sikkerhed bekræfter, at alvorlige bivirkninger efter vaccination sjældne.
Eurosurveillance latest updates
23.02.2024
…ce and vaccine coverage data, even if these data cannot be linked. In Germany, where notification data, laboratory testing data, and vaccine coverage data cannot be linked due to strict data protection requirements, the screening method was used to assess COVID-19 VE continuously between July 2021 and March 2023. During this period, when Delta and Omicron variants circulated, VE estimates were produced in real-time for different age groups and clinical outcomes. Here we describe the country’s overall posi…
Eurosurveillance latest updates
23.02.2024
. Background. Wastewater surveillance has expanded globally as a means to monitor spread of infectious diseases. An inherent challenge is substantial noise and bias in wastewater data because of the sampling and quantification process, limiting the applicability of wastewater surveillance as a monitoring tool. . . Aim. To present an analytical framework for capturing the growth trend of circulating infections from wastewater data and conducting scenario analyses to guide policy decisions. . . Methods.…
Morbidity and Mortality Weekly Report (MMWR)
22.02.2024
This report describes an increase in Mycoplasma pneumoniae, a common cause of respiratory illness, beginning in fall 2023.
Medscape Infectious Diseases
22.02.2024
Italy has spent around 45% of the almost 102 billion euros ($110.7 billion) it has received so far from European Union COVID-19 recovery funds, short of a target set in. . Reuters Health Information
Statens Serum Institut
22.02.2024
I den brede danske befolkning blev der diagnosticeret flere neurologiske lidelser efter smitte med covid-19. Det viser en ny stor undersøgelse fra Statens Serum Institut, hvor der indgik knap 1,8 mio smittede danskere.
Medscape Infectious Diseases
22.02.2024
Dysfunctional complement system proteins could explain chronic inflammation, fatigue, and other long COVID symptoms, leading to new treatments. . Medscape Medical News
Medscape Infectious Diseases
22.02.2024
The CDC's Pragna Patel, MD, MPH, and Dallas Smith, PharmD, answer common questions on COVID-19 rebound cases and antiviral treatment. . CDC Expert Commentary
Eurosurveillance latest updates
16.02.2024
Many vaccine effectiveness (VE) analyses of severe disease outcomes such as hospitalisation and death include ‘false’ cases that are not actually caused by the infection or disease under study. While the inclusion of such false cases inflate outcome rates in both vaccinated and unvaccinated populations, it is less obvious how they affect estimates of VE. Illustrating the main points through simple examples, this article shows how VE is underestimated when false cases are included as outcomes. Depending …
Morbidity and Mortality Weekly Report (MMWR)
16.02.2024
This report describes the prevalence of adults who reported ever experiencing Long COVID.
Medscape Infectious Diseases
14.02.2024
'Stupidest thing I've ever done': A lack of urgency surrounding virus spread and boosters may be triggering additional long COVID cases. . Medscape Medical News
ECDC COVID-19 updates
13.02.2024
This protocol presents a common updated methodology to estimate vaccine effectiveness (VE) for COVID-19, using established health data registries in participating European Union and European Economic Area (EU/EEA) countries.
Medscape Infectious Diseases
8.02.2024
Long-COVID sufferers of brain fog and memory loss exhibit elevated biomarkers consistent with brain injury. . Medscape Medical News
Statens Serum Institut
8.02.2024
Særligt på sociale medier har der gennem længere tid floreret en myte om, at de første små partier af covid-19 vaccinen ikke havde samme kvalitet som de senere større partier, og at de derfor førte til langt flere bivirkninger. Denne myte punkteres nu i en ny stor undersøgelse fra Statens Serum Institut.
ECDC COVID-19 updates
6.02.2024
This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
ECDC COVID-19 updates
2.02.2024
This downloadable data file contains information on COVID-19 vaccination in the EU/EEA since September 2023.
Medscape Infectious Diseases
1.02.2024
Amid the current winter wave surge of respiratory virus cases, how challenging is it for physician's to distinguish between, diagnose, and treat COVID-19 vs RSV and influenza? . Medscape Medical News
ECDC COVID-19 updates
26.01.2024
This report presents an interim description of COVID-19 vaccine coverage in the European Union/European Economic Area (EU/EEA) between 1 September 2023 and January 2024.

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2024 Dansk Selskab for Infektionsmedicin

CVR: 33634307

www.infmed.dk
Version: 2.12.2
PHP version: 8.0.30
Design: Christian Philip Fischer
Side indlæst på 0.709 s

Cookies og privatliv